CD4 and breast carcinoma: Considering the complex composition of breast cancer immunoinfiltrates (including CD8+ and CD4+ T-lymphocytes, regulatory T-cells or macrophages), future studies will have to show whether the -652 InsDel polymorphism takes an influence on TIL composition.